Acquired Pelger-Huët anomaly associated with ibuprofen therapy

Clinica Chimica Acta

Volumn 409, Issue 1-2, 2009, Pages 140-141

  Moreira, Andréia Maria Braz ^a   Vieira, Lauro Mello ^a   Rios, Danyelle Romana Alves ^a   Carvalho, Maria das Graças ^a   Dusse, Luci Maria Sant Ana ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; IBUPROFEN;

BLOOD ANALYSIS; CASE REPORT; CELL NUCLEUS; CHILD; DISEASE ASSOCIATION; EOSINOPHIL COUNT; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; HUMAN; LETTER; LEUKOCYTE COUNT; LEUKOCYTE DISORDER; LYMPHOCYTE COUNT; MONOCYTE; NEUTROPHIL COUNT; PRIORITY JOURNAL; SCHOOL CHILD;

CHILD; CHROMATIN; FEMALE; HUMANS; IBUPROFEN; NEUTROPHILS; PELGER-HUET ANOMALY;

EID: 70349823181     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.08.006     Document Type: Letter

References (15)

1. Johnson C.A., Cass D.A., Trillo A.A., Snyder M.S., and Dechatelet L.R. Functional and metabolic studies of polymorphonuclear leukocytes in the congenital Pelger-Huët anomaly. Blood 55 (1980) 466-469
2. Shetty V.T., Mundle S.D., and Raza A. Pseudo anomalia de Pelger-Huët anomaly in myelodysplastic syndrome: hyposegmented or apoptotic neutrophil?. Blood 98 (2001) 1273-1275
3. Kuriyama K., Tomonaga M., and Matsuo T. Diagnostic significance of detecting pseudo Pelger-Huët anomalies and micro-megakaryocytes in myelodysplastic syndrome. Br J Haematol 63 (1986) 665-669
4. Daliphard S., Accard F., Delattre C., Toupance D., Guyot C., Méchinaud F., et al. Reversible abnormal chromatin clumping in granulocytes from six transplant patients treated with mycophenolate mofetil: a rare adverse effect mimicking abnormal chromatin clumping syndrome. Br J Haematol 116 3 (2002) 726-727
5. Gondo H., Okamura C., Osaki K., Asano Y., and Okamura T. Acquired Pelger-Hüet anomaly in association with concomitant tacrolimus and fluconazol therapy following allogeneic bone marrow transplantation. Bone Marrow Transplant 26 (2000) 1255-1257
6. Juneja S.K., Matthews J.P., Luzinat R., Fan Y., Michael M., Rischin D., et al. Association of acquired Pelger-Huët anomaly with taxoid therapy. Br J Haematol 93 (1996) 139-141
7. Kaplan J.M., and Barrett Jr. O. Reversible pseudo anomalia de Pelger anomaly related to sulfisoxazole therapy. N Engl J Med 277 (1967) 421-422
8. May R.B., and Sunder T.R. Hematologic manifestations of long-term valproate therapy. Epilepsia 34 (1993) 1098-1101
9. Oka Y., Kameoka J., Hirabayashi Y., Takahashi R., Ishii T., Sasaki T., et al. Reversible bone marrow dysplasia in patients with systemic lupus erythematosus. Inter Med 47 (2008) 737-742
10. Dusse L.M., Morais R.M.S., Freitas V.M., Medeiros G.M., Vieira L.M., and Carvalho M.G. Pseudo Pelger-Huët in transplanted patients. Acta Haematologica 116 (2006) 272-274
11. Deutsch P.H., and Mandell G.L. Reversible Pelger-Huët anomaly associated with ibuprofen therapy. Arch Intern Med 145 1 (1985) 166
12. Best S., Salvati F., Kallo J., Garner C., Height S., Thein S.L., et al. Lamin B-receptor mutations in Pelger-Huët anomaly. Br J Haematol 123 3 (2003) 542-544
13. Tomonaga M. Nuclear abnormalities in Pelger-Huet anomaly: progress in blood cell morphology. Rinsho Byori 52 1 (2005) 54-60
14. Soenen V., Preudhomme C., Roumier C., Daudignon A., Laï J.L., and Fenaux P. 17p Deletion in acute myeloid leukemia and myelodysplastic syndrome. Analysis of breakpoints and deleted segments by fluorescence in situ. Blood 91 (1998) 1008-1015
15. Cunningham J.M., Patnaik M.M., Hammerschmidt D.E., and Vercellotti G.M. Historical perspective and clinical implications of the Pelger-Huët cell. Am J Hematol 84 (2009) 116-119